within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AB10_Tinzaparin;

model Tinzaparin
  extends Pharmacolibrary.Drugs.ATC.B.B01AB10;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>B01AB10</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Tinzaparin is a low molecular weight heparin (LMWH) used for the prevention and treatment of deep vein thrombosis and pulmonary embolism. It is administered parenterally and is approved for clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers, both sexes, after subcutaneous administration.</p><h4>References</h4><ol><li><p>Helfer, H, et al., &amp; Mahé, I (2020). Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications. <i>American journal of cardiovascular drugs : drugs, devices, and other interventions</i> 20(3) 223–228. DOI:<a href=&quot;https://doi.org/10.1007/s40256-019-00382-0&quot;>10.1007/s40256-019-00382-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31721053/&quot;>https://pubmed.ncbi.nlm.nih.gov/31721053</a></p></li><li><p>Gouin-Thibault, I, et al., &amp; Delavenne, X (2024). Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study. <i>Journal of thrombosis and haemostasis : JTH</i> 22(10) 2864–2872. DOI:<a href=&quot;https://doi.org/10.1016/j.jtha.2024.07.006&quot;>10.1016/j.jtha.2024.07.006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39019439/&quot;>https://pubmed.ncbi.nlm.nih.gov/39019439</a></p></li><li><p>Neely, JL, et al., &amp; Lenhart, SE (2002). Tinzaparin sodium: a low-molecular-weight heparin. <i>American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists</i> 59(15) 1426–1436. DOI:<a href=&quot;https://doi.org/10.1093/ajhp/59.15.1426&quot;>10.1093/ajhp/59.15.1426</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12166042/&quot;>https://pubmed.ncbi.nlm.nih.gov/12166042</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Tinzaparin;
